- Home
- EBMT vs ANVS Comparison
EBMT vs ANVS Comparison
Compare EBMT & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBMT
- ANVS
- Stock Information
- Founded
- EBMT 1922
- ANVS 2008
- Country
- EBMT United States
- ANVS United States
- Employees
- EBMT N/A
- ANVS N/A
- Industry
- EBMT Major Banks
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- EBMT Finance
- ANVS Health Care
- Exchange
- EBMT Nasdaq
- ANVS Nasdaq
- Market Cap
- EBMT 120.7M
- ANVS 110.4M
- IPO Year
- EBMT N/A
- ANVS 2020
- Fundamental
- Price
- EBMT $15.79
- ANVS $8.43
- Analyst Decision
- EBMT
- ANVS Strong Buy
- Analyst Count
- EBMT 0
- ANVS 5
- Target Price
- EBMT N/A
- ANVS $30.60
- AVG Volume (30 Days)
- EBMT 10.1K
- ANVS 155.9K
- Earning Date
- EBMT 10-22-2024
- ANVS 11-06-2024
- Dividend Yield
- EBMT 3.61%
- ANVS N/A
- EPS Growth
- EBMT N/A
- ANVS N/A
- EPS
- EBMT 1.08
- ANVS N/A
- Revenue
- EBMT $80,564,000.00
- ANVS N/A
- Revenue This Year
- EBMT N/A
- ANVS N/A
- Revenue Next Year
- EBMT $7.72
- ANVS N/A
- P/E Ratio
- EBMT $14.61
- ANVS N/A
- Revenue Growth
- EBMT N/A
- ANVS N/A
- 52 Week Low
- EBMT $11.26
- ANVS $4.53
- 52 Week High
- EBMT $17.65
- ANVS $22.49
- Technical
- Relative Strength Index (RSI)
- EBMT 62.76
- ANVS 51.10
- Support Level
- EBMT $15.49
- ANVS $7.84
- Resistance Level
- EBMT $15.85
- ANVS $8.36
- Average True Range (ATR)
- EBMT 0.25
- ANVS 0.53
- MACD
- EBMT -0.04
- ANVS 0.04
- Stochastic Oscillator
- EBMT 56.67
- ANVS 36.31
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.